Growth Metrics

Pulmonx (LUNG) EBT Margin (2019 - 2025)

Pulmonx (LUNG) reported EBT Margin of 64.31% for Q3 2025, up 412.0% year-over-year from 12.56% in Q3 2024, and down 2.33% on a QoQ basis from 62.85% in Q2 2025.

Pulmonx (LUNG) has 7 years of EBT Margin data on file, last reported at 64.31% in Q3 2025.

  • Quarterly EBT Margin rose 412.0% year-over-year to 64.31% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 61.39% (up 972.0% YoY) and the FY2024 annual result came in at 66.71%, up 2106.0% from the prior year.
  • EBT Margin declined to 64.31% in Q3 2025 per LUNG's latest filing, from 62.85% in the prior quarter.
  • Across five years, EBT Margin topped out at 55.28% in Q4 2024 and bottomed at 146.14% in Q1 2022.
  • The 5-year median for EBT Margin is 84.0% (2023), against an average of 88.06%.
  • Peak annual rise in EBT Margin reached 21720 bps in 2021, while the deepest fall reached 5252 bps in 2021.
  • Tracing LUNG's EBT Margin over 5 years: stood at 93.77% in 2021, then rose by 3 bps to 91.0% in 2022, then advanced by 22 bps to 70.75% in 2023, then increased by 22 bps to 55.28% in 2024, then declined by 16 bps to 64.31% in 2025.
  • Per Business Quant, the three latest LUNG EBT Margin figures stand at 64.31% (Q3 2025), 62.85% (Q2 2025), and 63.51% (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 Pulmonx 67.30 Mn -2.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -64.31%
Jun 30, 2025 -62.85%
Mar 31, 2025 -63.51%
Dec 31, 2024 -55.28%
Sep 30, 2024 -68.44%
Jun 30, 2024 -73.34%
Mar 31, 2024 -71.94%
Dec 31, 2023 -70.75%
Sep 30, 2023 -84.00%
Jun 30, 2023 -93.38%
Mar 31, 2023 -108.26%
Dec 31, 2022 -91.00%
Sep 30, 2022 -104.96%
Jun 30, 2022 -104.66%
Mar 31, 2022 -146.14%
Dec 31, 2021 -93.77%
Sep 30, 2021 -76.44%
Jun 30, 2021 -105.56%
Mar 31, 2021 -134.63%
Dec 31, 2020 -94.36%
Sep 30, 2020 -35.91%
Jun 30, 2020 -322.76%
Mar 31, 2020 -82.11%
Dec 31, 2019 -43.70%
Sep 30, 2019 -46.64%